{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:43:17Z","timestamp":1787020997484,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UM1DA049417"],"award-info":[{"award-number":["UM1DA049417"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UM1DA049417"],"award-info":[{"award-number":["UM1DA049417"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UM1DA049417"],"award-info":[{"award-number":["UM1DA049417"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UM1DA049417"],"award-info":[{"award-number":["UM1DA049417"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UM1DA049417"],"award-info":[{"award-number":["UM1DA049417"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UM1DA049417"],"award-info":[{"award-number":["UM1DA049417"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Justice"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid-related overdose is a leading cause of death for criminal legal-involved individuals and, although naloxone distribution and medications for opioid use disorder (MOUD) are effective means for reducing post-release overdose death risk, jail-based availability is limited. This case report describes the challenges faced by three Ohio communities as they implemented evidence-based practices (EBPs) in jails to combat post-release opioid overdose deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We present case examples of how barriers were overcome to implement jail-based EBPs in three Ohio communities (two urban and one rural) as part of the HEALing Communities Study (UM1DA049417; ClinicalTrials.gov Identifier: NCT04111939). Of the 18 participating Ohio HEALing Communities Study counties, we highlight 3 communities for the novelty of their EBPs implemented, the challenges that they faced, and their rural\/urban status. We present descriptive data regarding the EBPs that they implemented and discuss the challenges identified by HEALing Communities Study staff with first-hand experience facilitating their implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Newly implemented interventions included overdose education and direct provision of naloxone to incarcerated individuals upon release (2 of 3 communities), initiating MOUD prior to release (3 of 3), linkage to ongoing MOUD treatment in the community (2 of 3), peer support-facilitated treatment retention efforts (2 of 3) and emergency housing (1 of 3) in the immediate post-incarceration period. Common challenges that emerged included skepticism about the need and feasibility of implementing EBPs to reduce overdose and death, lack of knowledge about the options available and whether external agencies may assist, and difficulty engaging stakeholders to overcome inertia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Creative flexibility, calm persistence, technical facilitation, and collaboration with community service providers were assets that helped these Ohio jails implement evidence-based strategies that combat the opioid epidemic and reduce the likelihood of post-incarceration overdose and death in a high risk, formerly incarcerated population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40352-024-00307-3","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T03:16:51Z","timestamp":1733368611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Jail-based interventions to reduce risk for opioid-related overdose deaths: Examples of implementation within Ohio counties participating in the HEALing Communities Study"],"prefix":"10.1186","volume":"12","author":[{"given":"Joel","family":"Sprunger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Rubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. John","family":"Winhusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"307_CR1","doi-asserted-by":"publisher","first-page":"108329","DOI":"10.1016\/j.drugalcdep.2020.108329","volume":"217","author":"RK Chandler","year":"2020","unstructured":"Chandler, R. K., Villani, J., Clarke, T., McCance-Katz, E. F., & Volkow, N. D. (2020). Addressing opioid overdose deaths: The vision for the HEALing communities study. Drug and Alcohol Dependence, 217, 108329. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108329","journal-title":"Drug and Alcohol Dependence"},{"key":"307_CR2","doi-asserted-by":"publisher","first-page":"111274","DOI":"10.1016\/j.drugalcdep.2024.111274","volume":"259","author":"T Cherian","year":"2024","unstructured":"Cherian, T., Lim, S., Katyal, M., Goldfeld, K. S., McDonald, R., Wiewel, E., Khan, M., Krawczyk, N., Braunstein, S., Murphy, S. M., Jalali, A., Jeng, P. J., Rosner, Z., MacDonald, R., & Lee, J. D. (2024). Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration. Drug and Alcohol Dependence, 259, 111274. https:\/\/doi.org\/10.1016\/j.drugalcdep.2024.111274","journal-title":"Drug and Alcohol Dependence"},{"key":"307_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.addbeh.2018.12.017","volume":"92","author":"PJ Davidson","year":"2019","unstructured":"Davidson, P. J., Wagner, K. D., Tokar, P. L., & Scholar, S. (2019). Documenting need for naloxone distribution in the Los Angeles County jail system. Addictive Behaviors, 92, 20\u201323. https:\/\/doi.org\/10.1016\/j.addbeh.2018.12.017","journal-title":"Addictive Behaviors"},{"issue":"1","key":"307_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1471-2458-14-297","volume":"14","author":"M Doe-Simkins","year":"2014","unstructured":"Doe-Simkins, M., Quinn, E., Xuan, Z., Sorensen-Alawad, A., Hackman, H., Ozonoff, A., & Walley, A. Y. (2014). Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: A retrospective cohort study. Bmc Public Health, 14(1), 297. https:\/\/doi.org\/10.1186\/1471-2458-14-297","journal-title":"Bmc Public Health"},{"key":"307_CR6","doi-asserted-by":"publisher","first-page":"108327","DOI":"10.1016\/j.drugalcdep.2020.108327","volume":"217","author":"N El-Bassel","year":"2020","unstructured":"El-Bassel, N., Jackson, R. D., Samet, J., & Walsh, S. L. (2020). Introduction to the special issue on the HEALing communities Study. Drug and Alcohol Dependence, 217, 108327. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108327","journal-title":"Drug and Alcohol Dependence"},{"key":"307_CR7","doi-asserted-by":"publisher","first-page":"102768","DOI":"10.1016\/j.drugpo.2020.102768","volume":"81","author":"CE Grella","year":"2020","unstructured":"Grella, C. E., Ostile, E., Scott, C. K., Dennis, M., & Carnavale, J. (2020). A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the Criminal Justice System. International Journal of Drug Policy, 81, 102768. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102768","journal-title":"International Journal of Drug Policy"},{"key":"307_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.addbeh.2017.11.029","volume":"86","author":"Z Huxley-Reicher","year":"2018","unstructured":"Huxley-Reicher, Z., Maldjian, L., Winkelstein, E., Siegler, A., Paone, D., Tuazon, E., Nolan, M. L., Jordan, A., MacDonald, R., & Kunins, H. V. (2018). Witnessed overdoses and naloxone use among visitors to Rikers Island jails trained in overdose rescue. Addictive Behaviors, 86, 73\u201378. https:\/\/doi.org\/10.1016\/j.addbeh.2017.11.029","journal-title":"Addictive Behaviors"},{"issue":"6","key":"307_CR9","doi-asserted-by":"publisher","first-page":"S211","DOI":"10.1016\/j.amepre.2007.02.015","volume":"32","author":"TP Johnson","year":"2007","unstructured":"Johnson, T. P., & Fendrich, M. (2007). Homelessness and drug use: Evidence from a community sample. American Journal of Preventive Medicine, 32(6), S211\u2013S218. https:\/\/doi.org\/10.1016\/j.amepre.2007.02.015","journal-title":"American Journal of Preventive Medicine"},{"issue":"1","key":"307_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","volume":"14","author":"PJ Joudrey","year":"2019","unstructured":"Joudrey, P. J., Khan, M. R., Wang, E. A., Scheidell, J. D., Edelman, E. J., McInnes, D. K., & Fox, A. D. (2019). A conceptual model for understanding post-release opioid-related overdose risk. Addiction Science & Clinical Practice, 14(1), 17. https:\/\/doi.org\/10.1186\/s13722-019-0145-5","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"307_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13722-022-00313-6","volume":"17","author":"N Krawczyk","year":"2022","unstructured":"Krawczyk, N., Bandara, S., Merritt, S., Shah, H., Duncan, A., McEntee, B., Schiff, M., Ahmad, N. J., Whaley, S., Latimore, A., & Saloner, B. (2022). Jail-based treatment for opioid use disorder in the era of bail reform: A qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative. Addiction Science & Clinical Practice, 17(1), 30. https:\/\/doi.org\/10.1186\/s13722-022-00313-6","journal-title":"Addiction Science & Clinical Practice"},{"issue":"3","key":"307_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018). Medication for opioid Use Disorder after Nonfatal Opioid Overdose and Association with Mortality: A Cohort Study. Annals of Internal Medicine, 169(3), 137\u2013145. https:\/\/doi.org\/10.7326\/M17-3107","journal-title":"Annals of Internal Medicine"},{"issue":"10118","key":"307_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","volume":"391","author":"JD Lee","year":"2018","unstructured":"Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., Peavy, K. M., Ross, S., Salazar, D., Schkolnik, P., & Rotrosen, J. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial. Lancet (London England), 391(10118), 309\u2013318. https:\/\/doi.org\/10.1016\/S0140-6736(17)32812-X","journal-title":"Lancet (London England)"},{"issue":"3","key":"307_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/add.16071","volume":"118","author":"S Lim","year":"2023","unstructured":"Lim, S., Cherian, T., Katyal, M., Goldfeld, K. S., McDonald, R., Wiewel, E., Khan, M., Krawczyk, N., Braunstein, S., Murphy, S. M., Jalali, A., Jeng, P. J., MacDonald, R., & Lee, J. D. (2023). Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011\u201317. Addiction, 118(3), 459\u2013467. https:\/\/doi.org\/10.1111\/add.16071","journal-title":"Addiction"},{"key":"307_CR15","doi-asserted-by":"publisher","first-page":"107858","DOI":"10.1016\/j.drugalcdep.2020.107858","volume":"208","author":"A Macmadu","year":"2020","unstructured":"Macmadu, A., Goedel, W. C., Adams, J. W., Brinkley-Rubinstein, L., Green, T. C., Clarke, J. G., Martin, R. A., Rich, J. D., & Marshall, B. D. L. (2020). Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails. Drug and Alcohol Dependence, 208, 107858. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107858","journal-title":"Drug and Alcohol Dependence"},{"key":"307_CR16","unstructured":"Maruschak, L. M., Minton, T. D., & Zeng, Z. (2023). Opioid Use Disorder Screening and Treatment in Local Jails, 2019 (NCJ 305179). U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics."},{"issue":"1","key":"307_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","volume":"105","author":"A Nunn","year":"2009","unstructured":"Nunn, A., Zaller, N., Dickman, S., Trimbur, C., Nijhawan, A., & Rich, J. D. (2009). Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide Survey. Drug and Alcohol Dependence, 105(1), 83\u201388. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.06.015","journal-title":"Drug and Alcohol Dependence"},{"key":"307_CR18","doi-asserted-by":"publisher","first-page":"109655","DOI":"10.1016\/j.drugalcdep.2022.109655","volume":"241","author":"AW O\u2019Connor","year":"2022","unstructured":"O\u2019Connor, A. W., Sears, J. M., & Fulton-Kehoe, D. (2022). Overdose and substance-related mortality after release from prison in Washington State: 2014\u20132019. Drug and Alcohol Dependence, 241, 109655. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109655","journal-title":"Drug and Alcohol Dependence"},{"key":"307_CR19","unstructured":"Ohio Board of Pharmacy (2021, July 14). Personally Furnishing Discharge Medications to Patients Leaving Correctional Facilities. https:\/\/pharmacy.ohio.gov\/Documents\/Pubs\/Special\/DangerousDrugs\/Personally%20Furnishing%20Discharge%20Medications%20to%20Patients%20Leaving%20Correctional%20Facilities.pdf"},{"key":"307_CR20","unstructured":"Ohio Department of Health. (n.d.). Project DAWN, & Project, D. A. W. N. (2024). Retrieved June 25, from https:\/\/odh.ohio.gov\/know-our-programs\/project-dawn\/"},{"issue":"4","key":"307_CR21","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1016\/j.annemergmed.2023.08.328","volume":"82","author":"K Paul","year":"2023","unstructured":"Paul, K., Frey, C., Truong, S., Paglicawan, L., v, Cunningham, K., Golovko, G., Hill, T. P., & Jehle, D. (2023). 303 suboxone for opioid use disorder: Reduction in mortality and increased remission. Annals of Emergency Medicine, 82(4), S132\u2013S133. https:\/\/doi.org\/10.1016\/j.annemergmed.2023.08.328","journal-title":"Annals of Emergency Medicine"},{"issue":"9","key":"307_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo","year":"2021","unstructured":"Santo, T., Jr, Clark, B., Hickman, M., Grebely, J., Campbell, G., Sordo, L., Chen, A., Tran, L. T., Bharat, C., Padmanathan, P., Cousins, G., Dupouy, J., Kelty, E., Muga, R., Nosyk, B., Min, J., Pavarin, R., Farrell, M., & Degenhardt, L. (2021). Association of Opioid Agonist Treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and Meta-analysis. JAMA Psychiatry, 78(9), 979\u2013993. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0976","journal-title":"JAMA Psychiatry"},{"key":"307_CR23","doi-asserted-by":"publisher","first-page":"114293","DOI":"10.1016\/j.socscimed.2021.114293","volume":"285","author":"D Showalter","year":"2021","unstructured":"Showalter, D., Wenger, L. D., Lambdin, B. H., Wheeler, E., Binswanger, I., & Kral, A. H. (2021). Bridging institutional logics: Implementing naloxone distribution for people exiting jail in three California counties. Social Science & Medicine, 285, 114293. https:\/\/doi.org\/10.1016\/j.socscimed.2021.114293","journal-title":"Social Science & Medicine"},{"key":"307_CR24","doi-asserted-by":"publisher","first-page":"108326","DOI":"10.1016\/j.drugalcdep.2020.108326","volume":"217","author":"L Sprague Martinez","year":"2020","unstructured":"Sprague Martinez, L., Rapkin, B. D., Young, A., Freisthler, B., Glasgow, L., Hunt, T., Salsberry, P. J., Oga, E. A., Bennet-Fallin, A., Plouck, T. J., Drainoni, M. L., Freeman, P. R., Surratt, H., Gulley, J., Hamilton, G. A., Bowman, P., Roeber, C. A., El-Bassel, N., & Battaglia, T. (2020). Community engagement to implement evidence-based practices in the HEALing communities study. Drug and Alcohol Dependence, 217, 108326. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108326","journal-title":"Drug and Alcohol Dependence"},{"key":"307_CR25","doi-asserted-by":"publisher","unstructured":"The HEALing Communities Study Consortium. (2024). Community-based cluster-randomized trial to reduce opioid overdose deaths. New England Journal of Medicine, NEJMoa2401177. https:\/\/doi.org\/10.1056\/NEJMoa2401177","DOI":"10.1056\/NEJMoa2401177"},{"issue":"1","key":"307_CR26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/08897077.2022.2060448","volume":"43","author":"PC Treitler","year":"2022","unstructured":"Treitler, P. C., Enich, M., Reeves, D., & Crystal, S. (2022). Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons. Substance Abuse, 43(1), 964\u2013971. https:\/\/doi.org\/10.1080\/08897077.2022.2060448","journal-title":"Substance Abuse"},{"key":"307_CR27","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. Bmj, 346, f174. https:\/\/doi.org\/10.1136\/bmj.f174","journal-title":"Bmj"},{"key":"307_CR28","doi-asserted-by":"publisher","first-page":"108335","DOI":"10.1016\/j.drugalcdep.2020.108335","volume":"217","author":"SL Walsh","year":"2020","unstructured":"Walsh, S. L., El-Bassel, N., Jackson, R. D., Samet, J. H., Aggarwal, M., Aldridge, A. P., Baker, T., Barbosa, C., Barocas, J. A., Battaglia, T. A., Beers, D., Bernson, D., Bowers-Sword, R., Bridden, C., Brown, J. L., Bush, H. M., Bush, J. L., Button, A., Campbell, A. N. C., & Chandler, R. K. (2020). The HEALing (helping to End Addiction Long-Term SM) communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices. Drug and Alcohol Dependence, 217, 108335. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108335","journal-title":"Drug and Alcohol Dependence"},{"key":"307_CR29","doi-asserted-by":"publisher","first-page":"108325","DOI":"10.1016\/j.drugalcdep.2020.108325","volume":"217","author":"T Winhusen","year":"2020","unstructured":"Winhusen, T., Walley, A., Fanucchi, L. C., Hunt, T., Lyons, M., Lofwall, M., Brown, J. L., Freeman, P. R., Nunes, E., Beers, D., Saitz, R., Stambaugh, L., Oga, E. A., Herron, N., Baker, T., Cook, C. D., Roberts, M. F., Alford, D. P., Starrels, J. L., & Chandler, R. K. (2020). The opioid-overdose reduction continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing communities Study. Drug and Alcohol Dependence, 217, 108325. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108325","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"307_CR30","doi-asserted-by":"publisher","first-page":"e059328","DOI":"10.1136\/bmjopen-2021-059328","volume":"12","author":"AM Young","year":"2022","unstructured":"Young, A. M., Brown, J. L., Hunt, T., Martinez, S., Chandler, L. S., Oga, R., Winhusen, E., Baker, T. J., Battaglia, T., Bowers-Sword, T., Button, R., Fallin-Bennett, A., Fanucchi, A., Freeman, L., Glasgow, P., Gulley, L. M., Kendell, J., Lofwall, C., Lyons, M., & Walsh, M. S., S. L (2022). Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing communities Study: A trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio. British Medical Journal Open, 12(9), e059328. https:\/\/doi.org\/10.1136\/bmjopen-2021-059328","journal-title":"British Medical Journal Open"}],"container-title":["Health &amp; Justice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-024-00307-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40352-024-00307-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-024-00307-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T05:52:49Z","timestamp":1733377969000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthandjusticejournal.biomedcentral.com\/articles\/10.1186\/s40352-024-00307-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1186\/s40352-024-00307-3","relation":{},"ISSN":["2194-7899"],"issn-type":[{"value":"2194-7899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol (Pro00038088) was approved by Advarra Inc., the HEALing Communities Study single Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}